With the aim to better clarify the role of tau pathology in MBI, another recent study by Naude and colleagues using amyloid and tau PET among non-demented individuals demonstrated that amyloid pathology status affected the relationship between MBI and tau pathology in the brain regions corresponding to the Braak I and III stages of AD [65]. Here, MAPT is linked to amyloidosis.